Academic Articles & Research Papers

Mechanistic biomarkers for cancer vaccine development: from cancer cell biology to neoantigen-guided precision immunotherapy.

Rusciano D • Frontiers in cell and developmental biology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fcell.2026.1897032 PMC: PMC13542416

View Article » Original Source ↗

QResearch primary care records linked to national hospital and cancer registry data: a validation study.

Kulkarni S, Perletta V, Wang Z, Tomlinson JW et al. • ESMO real world data and digital oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.esmorw.2026.100763 PMC: PMC13542614

View Article » Original Source ↗

Oncotype DX-guided vs physician-directed chemotherapy and survival in HR+/HER2- breast cancer.

Li J, Han X, Zhuang Y, Liu Y et al. • Breast (Edinburgh, Scotland) (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.breast.2026.104906 PMC: PMC13545399

View Article » Original Source ↗

Cancer Screening Behaviors among People with HIV in the United States and the Role of Multi-Level Social and Economic Factors: A Systematic Review.

Islam JY, Lappen H, Commaroto S, Edwards D et al. • Current epidemiology reports (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s40471-025-00378-2 PMC: PMC13540407

View Article » Original Source ↗

Environmental and public health outcomes following the Fundão dam collapse (Mariana, Brazil): a retrospective ecological study of drinking water quality and cancer mortality.

Panis C, Ponmattam J, Pires de Paula Filho AR, Paz RG et al. • Lancet regional health. Americas (2026)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.lana.2026.101615 PMC: PMC13545392

View Article » Original Source ↗

Evolving burden of pancreatic cancer in the Middle East and North Africa Region, 1990-2023: an analysis based on the Global Burden of Disease Study 2023.

Aljohani E, Albarrak A, Al-Khateeb BF, Alwatban N et al. • Journal of gastrointestinal oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.21037/jgo-2026-0539 PMC: PMC13546524

View Article » Original Source ↗

Redefining rurality: adopting an identity-based and community-engaged approach to defining rural cancer disparities.

Kauer T, Franco CL, Munroe DD, Doescher M et al. • Journal of the National Cancer Institute (2026)

PMC PMC Public Access (View-Only) DOI: 10.1093/jnci/djaf329 PMC: PMC13549715

View Article » Original Source ↗

Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts.

Pilco-Janeta DF, De la Cruz-Puebla M, Guamán-Pilco DR, Montenegro D et al. • Cancer research communications (2026)

PMC PMC Public Access (View-Only) DOI: 10.1158/2767-9764.CRC-26-0322 PMC: PMC13548115

View Article » Original Source ↗

First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials.

Rothweiler V, Roderburg C, Koeksal M, Jensen BEO et al. • Cancer reports (Hoboken, N.J.) (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/cnr2.70660 PMC: PMC13547580

View Article » Original Source ↗

Building bridges to immunotherapy: a knowledge-mapping analysis of cervical cancer organoid research.

Tian Y, Chang H, Liu J, Ding W et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1788725 PMC: PMC13547482

View Article » Original Source ↗

Cervical cancer survival for patients referred to a tertiary care center in Kentucky.

Seamon LG, Tarrant RL, Fleming ST, Vanderpool RC et al. • Gynecologic oncology (2011)

PMC PMC Public Access (View-Only) DOI: 10.1016/j.ygyno.2011.09.008 PMC: PMC13551475

View Article » Original Source ↗

A bibliometric analysis of artificial intelligence in ovarian cancer research from 2006 to 2025.

He J, Zhou W, He Y, Nie Y et al. • Discover oncology (2026)

PMC PMC Public Access (View-Only) DOI: 10.1007/s12672-026-05483-2 PMC: PMC13550375

View Article » Original Source ↗

Cancer care in Pakistan: a national survey of infrastructure, diagnostic capacity, therapeutic access, and workforce perspectives.

Shaikh AJ, Shaukat F, Sarwar A, Salam A et al. • BMC health services research (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12913-026-15519-6 PMC: PMC13551771

View Article » Original Source ↗

Cancer-associated fibroblasts as architects of acquired immune-privileged-like niches in gastrointestinal cancers: lessons from ocular immune privilege and barrier biology.

Wang Y, Wang Z, Zhou F, Qiao Y et al. • Frontiers in immunology (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fimmu.2026.1946857 PMC: PMC13549987

View Article » Original Source ↗

Trends and projections in cause-specific mortality among patients with colorectal cancer in the United States, 1999-2040.

He Z, Chen Y, Hu Y, Lin J et al. • Frontiers in public health (2026)

PMC PMC Public Access (View-Only) DOI: 10.3389/fpubh.2026.1850707 PMC: PMC13550207

View Article » Original Source ↗

Ecosystem-matched reprogramming of the tumor-immune microenvironment to overcome cancer immunotherapy resistance.

Wang X, Wang Q, Gao W, He S et al. • Molecular cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.1186/s12943-026-02748-w PMC: PMC13556080

View Article » Original Source ↗

Gastrointestinal Microbiome Dysbiosis in Cancer Development: Mechanisms and Biomarker Potential.

Asgari N, Asghari M, Farazmandfar T • MicrobiologyOpen (2026)

PMC PMC Public Access (View-Only) DOI: 10.1002/mbo3.70404 PMC: PMC13555811

View Article » Original Source ↗

A Multimethod Evaluation to Assess Feasibility, Acceptability, and Preliminary Efficacy of HPVVaxFacts, a Tailored Mobile Web App, for Parents With Unvaccinated Children: Pilot 2-Arm Randomized Controlled Trial.

Cunningham-Erves J, Hull PC, Dempsey AF, Koyama T et al. • JMIR cancer (2026)

PMC PMC Public Access (View-Only) DOI: 10.2196/78910 PMC: PMC13557614

View Article » Original Source ↗

The PROM1(+)SMAD5(+) Tumor-Initiating Subpopulation Shapes Premetastatic Niches through Spatial Multi-Omics Landscapes in HER2-Positive Breast Cancer.

Yin H, Wang W, Ge J, Fan G et al. • Cancer communications (London, England) (2026)

PMC PMC Public Access (View-Only) DOI: 10.34133/cancomm.0046 PMC: PMC13554431

View Article » Original Source ↗

Retraction Note: Dual role of ROS-dependent anti-cancer activity and photocatalytic degradation of graphene oxide against MCF-7 breast cancer cells and organic dye.

Chelliah CK, Rajivgandhi G, Maruthupandy M, Chackaravarthi G et al. • Scientific reports (2026)

PMC PMC Public Access (View-Only) DOI: 10.1038/s41598-026-64542-4 PMC: PMC13558547

View Article » Original Source ↗